4 hours Ago By Defense World Staff
Renaissance Technologies LLC trimmed its stake in Journey Medical Co. ( NASDAQ:DERM – Free Report ) by 12.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC.
The firm owned 236,000 shares of the company’s stock after selling 32,200 shares during the quarter. Renaissance Technologies LLC owned about 1.13% of Journey Medical worth $923,000 as of its most recent filing with the SEC.
Separately, Geode Capital Management LLC grew its holdings in Journey Medical by 13.5% in the third quarter. Geode Capital Management LLC now owns 108,435 shares of the company’s stock valued at $613,000 after purchasing an additional 12,882 shares during the period.
7.25% of the stock is owned by institutional investors and hedge funds. Analyst Ratings Changes A number of research firms recently issued reports on DERM.
Industrial Alliance Securities set a $10.50 target price on shares of Journey Medical in a report on Thursday, March 27th. Alliance Global Partners reiterated a “buy” rating on shares of Journey Medical in a research note on Thursday, March 27th.
Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $9.88.
Journey Medical Price Performance DERM opened at $7.42 on Thursday. The company has a quick ratio of 1.
03, a current ratio of 1.38 and a debt-to-equity ratio of 1.81.
Journey Medical Co. has a 52-week low of $3.20 and a 52-week high of $7.
84. The company has a 50 day moving average of $6.08 and a two-hundred day moving average of $5.
36. The company has a market cap of $171.43 million, a P/E ratio of -7.
89 and a beta of 0.90. Journey Medical ( NASDAQ:DERM – Get Free Report ) last released its quarterly earnings data on Wednesday, March 26th.
The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.
30. The company had revenue of $14.30 million during the quarter, compared to the consensus estimate of $14.
21 million. Journey Medical had a negative net margin of 31.74% and a negative return on equity of 132.
10%. On average, analysts expect that Journey Medical Co. will post -1.
02 earnings per share for the current year. Insider Activity In other news, CEO Claude Maraoui sold 14,905 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $5.
01, for a total value of $74,674.05. Following the completion of the transaction, the chief executive officer now directly owns 2,052,418 shares in the company, valued at approximately $10,282,614.
18. This represents a 0.72 % decrease in their ownership of the stock.
The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link . Over the last three months, insiders sold 105,831 shares of company stock worth $536,622. 13.
16% of the stock is currently owned by company insiders. Journey Medical Company Profile ( Free Report ) Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.
Read More Five stocks we like better than Journey Medical What is a Low P/E Ratio and What Does it Tell Investors? Why D-Wave’s Project With Davidson Is a Game-Changer For Quantum Are Penny Stocks a Good Fit for Your Portfolio? Hims & Hers Stock Soars on Novo Nordisk Collaboration Why Invest in 5G? How to Invest in 5G Stocks Amazon’s Earnings Will Make or Break the Stock’s Comeback Receive News & Ratings for Journey Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Journey Medical and related companies with MarketBeat.com's FREE daily email newsletter ..
